Autoantibodies against SUMO1-DHX35 in long-COVID
Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is...
Saved in:
| Published in | Journal of translational autoimmunity (Online) Vol. 5; p. 100171 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier B.V
01.01.2022
Published by Elsevier B.V Elsevier |
| Online Access | Get full text |
| ISSN | 2589-9090 2589-9090 |
| DOI | 10.1016/j.jtauto.2022.100171 |
Cover
| Abstract | Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is being further investigated. With the goal of identifying potentially unknown autoAbs, we screened plasma of patients with long COVID on in-house post-translationally modified protein macroarrays including citrullinated, SUMOylated and acetylated membranes. SUMO1ylated isoform DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 35 (SUMO1-DHX35) was identified as only candidate antigen. In adult patients with long COVID, IgG autoAbs against SUMO1-DHX35 of IgG class were found in seven of 71 (9.8%) plasma samples, of IgM and IgG class in one of 69 (1.4%) samples, not in 200 healthy adult controls, not in 442 healthy children, and 146 children after SARS-CoV-2 infection. All autoAb-positive seven patients were female. AutoAb titers ranged between 200 to up to 400 By point mutagenesis and expression of FLAG-tagged mutants of DHX35 in HEK293 cells, and subsequent SUMOylation of purified constructs, lysine 53 was identified as a unique, never yet identified, SUMOylation site. The autoAbs had no reactivity against the non-SUMO1ylated mutant (K53R) of DHX35. To summarize, autoAbs against SUMO1-DHX35 were identified in adult female patients with long-COVID. Further studies are needed to verify the frequency of occurrence. The function of DHX35 has not yet been determined and there is no available information in relation to disease implication. The molecular mechanism causing the SUMOylation, the potential functional consequences of this post-translational modification on DHX35, and a potential pathogenicity of the autoAbs against SUMO1-DHX35 in COVID-19 and other possible contexts remain to be elucidated.
•IgG autoantobodies against SUMO1-DHX35 occur in a subset of patients with long-COVID.•Lysine 53 was identified as SUMOylation site of DHX35•SUMOylation of DHX-35 is a necessary prerequisite for reactivity of autoantibodies |
|---|---|
| AbstractList | Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is being further investigated. With the goal of identifying potentially unknown autoAbs, we screened plasma of patients with long COVID on in-house post-translationally modified protein macroarrays including citrullinated, SUMOylated and acetylated membranes. SUMO1ylated isoform DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 35 (SUMO1-DHX35) was identified as only candidate antigen. In adult patients with long COVID, IgG autoAbs against SUMO1-DHX35 of IgG class were found in seven of 71 (9.8%) plasma samples, of IgM and IgG class in one of 69 (1.4%) samples, not in 200 healthy adult controls, not in 442 healthy children, and 146 children after SARS-CoV-2 infection. All autoAb-positive seven patients were female. AutoAb titers ranged between 200 to up to 400 By point mutagenesis and expression of FLAG-tagged mutants of DHX35 in HEK293 cells, and subsequent SUMOylation of purified constructs, lysine 53 was identified as a unique, never yet identified, SUMOylation site. The autoAbs had no reactivity against the non-SUMO1ylated mutant (K53R) of DHX35. To summarize, autoAbs against SUMO1-DHX35 were identified in adult female patients with long-COVID. Further studies are needed to verify the frequency of occurrence. The function of DHX35 has not yet been determined and there is no available information in relation to disease implication. The molecular mechanism causing the SUMOylation, the potential functional consequences of this post-translational modification on DHX35, and a potential pathogenicity of the autoAbs against SUMO1-DHX35 in COVID-19 and other possible contexts remain to be elucidated. Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is being further investigated. With the goal of identifying potentially unknown autoAbs, we screened plasma of patients with long COVID on in-house post-translationally modified protein macroarrays including citrullinated, SUMOylated and acetylated membranes. SUMO1ylated isoform DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 35 (SUMO1-DHX35) was identified as only candidate antigen. In adult patients with long COVID, IgG autoAbs against SUMO1-DHX35 of IgG class were found in seven of 71 (9.8%) plasma samples, of IgM and IgG class in one of 69 (1.4%) samples, not in 200 healthy adult controls, not in 442 healthy children, and 146 children after SARS-CoV-2 infection. All autoAb-positive seven patients were female. AutoAb titers ranged between 200 to up to 400 By point mutagenesis and expression of FLAG-tagged mutants of DHX35 in HEK293 cells, and subsequent SUMOylation of purified constructs, lysine 53 was identified as a unique, never yet identified, SUMOylation site. The autoAbs had no reactivity against the non-SUMO1ylated mutant (K53R) of DHX35. To summarize, autoAbs against SUMO1-DHX35 were identified in adult female patients with long-COVID. Further studies are needed to verify the frequency of occurrence. The function of DHX35 has not yet been determined and there is no available information in relation to disease implication. The molecular mechanism causing the SUMOylation, the potential functional consequences of this post-translational modification on DHX35, and a potential pathogenicity of the autoAbs against SUMO1-DHX35 in COVID-19 and other possible contexts remain to be elucidated.Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is being further investigated. With the goal of identifying potentially unknown autoAbs, we screened plasma of patients with long COVID on in-house post-translationally modified protein macroarrays including citrullinated, SUMOylated and acetylated membranes. SUMO1ylated isoform DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 35 (SUMO1-DHX35) was identified as only candidate antigen. In adult patients with long COVID, IgG autoAbs against SUMO1-DHX35 of IgG class were found in seven of 71 (9.8%) plasma samples, of IgM and IgG class in one of 69 (1.4%) samples, not in 200 healthy adult controls, not in 442 healthy children, and 146 children after SARS-CoV-2 infection. All autoAb-positive seven patients were female. AutoAb titers ranged between 200 to up to 400 By point mutagenesis and expression of FLAG-tagged mutants of DHX35 in HEK293 cells, and subsequent SUMOylation of purified constructs, lysine 53 was identified as a unique, never yet identified, SUMOylation site. The autoAbs had no reactivity against the non-SUMO1ylated mutant (K53R) of DHX35. To summarize, autoAbs against SUMO1-DHX35 were identified in adult female patients with long-COVID. Further studies are needed to verify the frequency of occurrence. The function of DHX35 has not yet been determined and there is no available information in relation to disease implication. The molecular mechanism causing the SUMOylation, the potential functional consequences of this post-translational modification on DHX35, and a potential pathogenicity of the autoAbs against SUMO1-DHX35 in COVID-19 and other possible contexts remain to be elucidated. Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is being further investigated. With the goal of identifying potentially unknown autoAbs, we screened plasma of patients with long COVID on in-house post-translationally modified protein macroarrays including citrullinated, SUMOylated and acetylated membranes. SUMO1ylated isoform DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 35 (SUMO1-DHX35) was identified as only candidate antigen. In adult patients with long COVID, IgG autoAbs against SUMO1-DHX35 of IgG class were found in seven of 71 (9.8%) plasma samples, of IgM and IgG class in one of 69 (1.4%) samples, not in 200 healthy adult controls, not in 442 healthy children, and 146 children after SARS-CoV-2 infection. All autoAb-positive seven patients were female. AutoAb titers ranged between 200 to up to 400 By point mutagenesis and expression of FLAG-tagged mutants of DHX35 in HEK293 cells, and subsequent SUMOylation of purified constructs, lysine 53 was identified as a unique, never yet identified, SUMOylation site. The autoAbs had no reactivity against the non-SUMO1ylated mutant (K53R) of DHX35. To summarize, autoAbs against SUMO1-DHX35 were identified in adult female patients with long-COVID. Further studies are needed to verify the frequency of occurrence. The function of DHX35 has not yet been determined and there is no available information in relation to disease implication. The molecular mechanism causing the SUMOylation, the potential functional consequences of this post-translational modification on DHX35, and a potential pathogenicity of the autoAbs against SUMO1-DHX35 in COVID-19 and other possible contexts remain to be elucidated. •IgG autoantobodies against SUMO1-DHX35 occur in a subset of patients with long-COVID.•Lysine 53 was identified as SUMOylation site of DHX35•SUMOylation of DHX-35 is a necessary prerequisite for reactivity of autoantibodies Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (autoAbs) has been postulated in long-COVID and is being further investigated. With the goal of identifying potentially unknown autoAbs, we screened plasma of patients with long COVID on in-house post-translationally modified protein macroarrays including citrullinated, SUMOylated and acetylated membranes. SUMO1ylated isoform DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 35 (SUMO1-DHX35) was identified as only candidate antigen. In adult patients with long COVID, IgG autoAbs against SUMO1-DHX35 of IgG class were found in seven of 71 (9.8%) plasma samples, of IgM and IgG class in one of 69 (1.4%) samples, not in 200 healthy adult controls, not in 442 healthy children, and 146 children after SARS-CoV-2 infection. All autoAb-positive seven patients were female. AutoAb titers ranged between 200 to up to 400 By point mutagenesis and expression of FLAG-tagged mutants of DHX35 in HEK293 cells, and subsequent SUMOylation of purified constructs, lysine 53 was identified as a unique, never yet identified, SUMOylation site. The autoAbs had no reactivity against the non-SUMO1ylated mutant (K53R) of DHX35. To summarize, autoAbs against SUMO1-DHX35 were identified in adult female patients with long-COVID. Further studies are needed to verify the frequency of occurrence. The function of DHX35 has not yet been determined and there is no available information in relation to disease implication. The molecular mechanism causing the SUMOylation, the potential functional consequences of this post-translational modification on DHX35, and a potential pathogenicity of the autoAbs against SUMO1-DHX35 in COVID-19 and other possible contexts remain to be elucidated. |
| ArticleNumber | 100171 |
| Author | Herr, Christian Muller, Sylviane Neumann, Frank Kos, Igor Age Schormann, Claudia Thurner, Lorenz Preuss, Klaus-Dieter Rixecker, Torben Millard Kessel, Christoph Kabesch, Michael Thurner, Bernhard Regitz, Evi Hoffmann, Marie-Christin Heyne, Kristina Cetin, Onur Lensch, Christian Fadle, Natalie Kheiroddin, Parastoo Bals, Robert Bewarder, Moritz |
| Author_xml | – sequence: 1 givenname: Lorenz surname: Thurner fullname: Thurner, Lorenz email: lorenz.thurner@uks.eu organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 2 givenname: Natalie surname: Fadle fullname: Fadle, Natalie organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 3 givenname: Evi surname: Regitz fullname: Regitz, Evi organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 4 givenname: Klaus-Dieter surname: Preuss fullname: Preuss, Klaus-Dieter organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 5 givenname: Frank surname: Neumann fullname: Neumann, Frank organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 6 givenname: Onur surname: Cetin fullname: Cetin, Onur organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 7 givenname: Claudia surname: Schormann fullname: Schormann, Claudia organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 8 givenname: Marie-Christin surname: Hoffmann fullname: Hoffmann, Marie-Christin organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 9 givenname: Christian surname: Herr fullname: Herr, Christian organization: Department of Internal Medicine V - Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany – sequence: 10 givenname: Parastoo surname: Kheiroddin fullname: Kheiroddin, Parastoo organization: University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany – sequence: 11 givenname: Torben Millard surname: Rixecker fullname: Rixecker, Torben Millard organization: Department of Internal Medicine V - Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany – sequence: 12 givenname: Robert surname: Bals fullname: Bals, Robert organization: Department of Internal Medicine V - Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany – sequence: 13 givenname: Sylviane surname: Muller fullname: Muller, Sylviane organization: Centre National de la Recherche Scientifique-Université de Strasbourg, Unit Biotechnology and Cell Signalling, Team Neuroimmunology and Peptide Therapeutics/Strasbourg Drug Discovery and Development Institute, Strasbourg, France – sequence: 14 givenname: Bernhard surname: Thurner fullname: Thurner, Bernhard organization: Department of Pediatrics, Klinikum Kempten, Germany – sequence: 15 givenname: Christoph surname: Kessel fullname: Kessel, Christoph organization: Department of Pediatric Rheumatology and Immunology, University Children's Hospital Muenster, Germany – sequence: 16 givenname: Michael surname: Kabesch fullname: Kabesch, Michael organization: University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany – sequence: 17 givenname: Moritz surname: Bewarder fullname: Bewarder, Moritz organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 18 givenname: Kristina surname: Heyne fullname: Heyne, Kristina organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany – sequence: 19 givenname: Christian surname: Lensch fullname: Lensch, Christian organization: Department of Internal Medicine V - Pulmonology, Allergology and Critical Care Medicine, Saarland University, Homburg, Germany – sequence: 20 givenname: Igor Age orcidid: 0000-0002-2518-7559 surname: Kos fullname: Kos, Igor Age organization: José Carreras Center for Immuno- and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar, Germany |
| BookMark | eNqFkcFu1DAURSNUJErpH7CYJZsM79mxnbBAqqZARyqaRVvEznpxnMFRxi62pxJ_T4YMEmXRrmw933tk-7wuTnzwtijeIiwRUL4flkOmfQ5LBoxNI0CFL4pTJuqmbKCBk3_2r4rzlAYAYAIRJTst4GKqks-uDZ2zaUFbcj7lxc3d1w2Wl1ffuVg4vxiD35arzbf15ZviZU9jsufH9ay4-_zpdnVVXm--rFcX16URIHMpgIu26Vnd91wJURMKhZIMA2Fq6EAqpZillqlWSewbIyo8JJFVnAvT8rNiPXO7QIO-j25H8ZcO5PSfQYhbTTE7M1rNKwHQEK8QqwoZa5GYJBCS6gYs2on1cWbd79ud7Yz1OdL4CPr4xLsfehsedCOVkJxPgHdHQAw_9zZlvXPJ2HEkb8M-aaYqEMiRyyn6YY6aGFKKttfGZcouHMhu1Aj6oE0PetamD9r0rG0qV_-V_97xmdrxfXYS8uBs1Mk4643tXLQmTz_mngb8Bq4ssY4 |
| CitedBy_id | crossref_primary_10_1016_j_prp_2023_154497 crossref_primary_10_3389_fimmu_2024_1341600 crossref_primary_10_3389_fmolb_2023_1157651 crossref_primary_10_1002_jmv_28864 crossref_primary_10_1002_mef2_70004 crossref_primary_10_3390_biom14070835 |
| Cites_doi | 10.1016/j.cmi.2021.11.002 10.3389/fonc.2020.580364 10.1002/iid3.270 10.1002/eji.202049163 10.1182/blood-2018-03-836932 10.1038/s41467-021-25509-3 10.1126/scitranslmed.abd3876 10.1172/JCI1316 10.1172/JCI76802 10.3389/fimmu.2021.707690 10.1016/j.jaci.2021.11.009 10.1101/2021.04.23.441188 10.1016/S2665-9913(22)00064-9 10.1016/j.autrev.2021.102792 10.1002/art.41409 10.1111/cts.12805 10.1016/S1473-3099(21)00703-9 10.1073/pnas.0812892106 10.1136/thoraxjnl-2020-216086 10.1001/jama.2020.12603 10.1002/ijc.24427 10.1097/HS9.0000000000000620 10.1136/bmjopen-2022-063505 10.1038/324258a0 10.1093/cid/ciaa1792 10.1016/j.jaut.2010.09.002 10.1016/j.bbih.2020.100056 10.1016/j.jaut.2012.10.003 10.1016/j.jtauto.2021.100100 10.1002/ana.21641 |
| ContentType | Journal Article |
| Copyright | 2023 The Authors 2022 Published by Elsevier B.V. 2022 Published by Elsevier B.V. 2022 |
| Copyright_xml | – notice: 2023 The Authors – notice: 2022 Published by Elsevier B.V. – notice: 2022 Published by Elsevier B.V. 2022 |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.jtauto.2022.100171 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2589-9090 |
| ExternalDocumentID | oai_doaj_org_article_345009a341144122b1a26a056a890e1e PMC9675633 10_1016_j_jtauto_2022_100171 S2589909022000326 |
| GroupedDBID | 0SF 53G 6I. AAEDW AAFTH AALRI AAXUO ACLIJ AEXQZ AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS EJD FDB GROUPED_DOAJ M41 M~E NCXOZ OK1 ROL RPM 0R~ AAYWO AAYXX ACVFH ADCNI ADVLN AEUPX AFJKZ AFPUW AIGII AKBMS AKYEP APXCP CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c506t-5035b9f28ff37558a15716ac205c80d067772eab27b761f9c541f375124335cb3 |
| IEDL.DBID | DOA |
| ISSN | 2589-9090 |
| IngestDate | Wed Aug 27 01:04:36 EDT 2025 Thu Aug 21 18:39:49 EDT 2025 Fri Jul 11 09:52:36 EDT 2025 Tue Jul 01 03:50:17 EDT 2025 Thu Apr 24 23:00:06 EDT 2025 Tue Jul 25 20:56:53 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c506t-5035b9f28ff37558a15716ac205c80d067772eab27b761f9c541f375124335cb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2518-7559 |
| OpenAccessLink | https://doaj.org/article/345009a341144122b1a26a056a890e1e |
| PQID | 2740513136 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_345009a341144122b1a26a056a890e1e pubmedcentral_primary_oai_pubmedcentral_nih_gov_9675633 proquest_miscellaneous_2740513136 crossref_citationtrail_10_1016_j_jtauto_2022_100171 crossref_primary_10_1016_j_jtauto_2022_100171 elsevier_sciencedirect_doi_10_1016_j_jtauto_2022_100171 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Journal of translational autoimmunity (Online) |
| PublicationYear | 2022 |
| Publisher | Elsevier B.V Published by Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Published by Elsevier B.V – name: Elsevier |
| References | Chang, Feng, Meng (bib11) 2021; 12 Bertin, Brodovitch, Beziane (bib12) 2020; 72 Thurner, Preuss, Bewarder (bib26) 2018; 132 Dotan, Muller, Kanduc, David, Halpert, Shoenfeld (bib7) 2021; 20 Bai, Tomasoni, Falcinella (bib6) 2022; 28 wei, zhong, Liu, Dong (bib10) 2021; 20 Merbl, Kirschner (bib24) 2009; 106 Soriano, Murthy, Marshall, Relan, Diaz (bib4) 2022; 22 Sivan, Greenhalgh, Darbyshire (bib5) 2022; 12 Zuo, Estes, Ali (bib9) 2020; 12 Dotan, Mahroum, Bogdanos, Shoenfeld (bib15) 2022; 149 Klemm, Assmann, Preuss (bib29) 2019; 7 Schellekens, de Jong, van den Hoogen, van de Putte, van Venrooij (bib33) 1998; 101 Bewarder, Kiefer, Moelle (bib28) 2020; 10 Preuss, Pfreundschuh, Fadle, Regitz, Kubuschok (bib23) 2015; 125 Massarenti, Enevold, Damgaard (bib31) 2021; 12 Carfì, Bernabei, Landi (bib2) 2020; 324 Thurner, Müller, Cérutti (bib22) 2011; 36 Arnold, Hamilton, Milne (bib1) 2021; 76 Wu, Tai, Hu (bib17) 2018; 9 Preuss, Pfreundschuh, Ahlgrimm (bib21) 2009; 125 Thurner L, Fadle N, Bewarder M, et al. AutoAbs against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19. bioRxiv. Published online October 20, 2021:2021.04.23.441188. doi:10.1101/2021.04.23.441188. Zhou, Han, Chen (bib14) 2020; 13 Thurner, Preuss, Fadle (bib25) 2013; 42 Pfeifer, Thurner, Kessel (bib20) 2022; 4 Owens, Bennett, Lassmann (bib30) 2009; 65 Petersen, Kristiansen, Hanusson (bib3) 2021; 73 Halpert, Amital, Shoenfeld (bib16) 2020; 4 Bewarder, Kiefer, Will (bib27) 2021; 5 Bastard, Rosen, Zhang (bib13) 2020 Zamvil, Mitchell, Moore, Kitamura, Steinman, Rothbard (bib32) 1986; 324 Wallukat, Hohberger, Wenzel (bib18) 2021; 4 Kos, Balensiefer, Lesan (bib8) 2021; 51 Petersen (10.1016/j.jtauto.2022.100171_bib3) 2021; 73 wei (10.1016/j.jtauto.2022.100171_bib10) 2021; 20 Thurner (10.1016/j.jtauto.2022.100171_bib22) 2011; 36 Wu (10.1016/j.jtauto.2022.100171_bib17) 2018; 9 Pfeifer (10.1016/j.jtauto.2022.100171_bib20) 2022; 4 Thurner (10.1016/j.jtauto.2022.100171_bib26) 2018; 132 Arnold (10.1016/j.jtauto.2022.100171_bib1) 2021; 76 Zhou (10.1016/j.jtauto.2022.100171_bib14) 2020; 13 Halpert (10.1016/j.jtauto.2022.100171_bib16) 2020; 4 Klemm (10.1016/j.jtauto.2022.100171_bib29) 2019; 7 Chang (10.1016/j.jtauto.2022.100171_bib11) 2021; 12 Schellekens (10.1016/j.jtauto.2022.100171_bib33) 1998; 101 Soriano (10.1016/j.jtauto.2022.100171_bib4) 2022; 22 Bewarder (10.1016/j.jtauto.2022.100171_bib28) 2020; 10 Zuo (10.1016/j.jtauto.2022.100171_bib9) 2020; 12 Bai (10.1016/j.jtauto.2022.100171_bib6) 2022; 28 Wallukat (10.1016/j.jtauto.2022.100171_bib18) 2021; 4 Dotan (10.1016/j.jtauto.2022.100171_bib7) 2021; 20 Bastard (10.1016/j.jtauto.2022.100171_bib13) 2020 Sivan (10.1016/j.jtauto.2022.100171_bib5) 2022; 12 Dotan (10.1016/j.jtauto.2022.100171_bib15) 2022; 149 Merbl (10.1016/j.jtauto.2022.100171_bib24) 2009; 106 Massarenti (10.1016/j.jtauto.2022.100171_bib31) 2021; 12 Preuss (10.1016/j.jtauto.2022.100171_bib23) 2015; 125 10.1016/j.jtauto.2022.100171_bib19 Preuss (10.1016/j.jtauto.2022.100171_bib21) 2009; 125 Bertin (10.1016/j.jtauto.2022.100171_bib12) 2020; 72 Thurner (10.1016/j.jtauto.2022.100171_bib25) 2013; 42 Owens (10.1016/j.jtauto.2022.100171_bib30) 2009; 65 Bewarder (10.1016/j.jtauto.2022.100171_bib27) 2021; 5 Zamvil (10.1016/j.jtauto.2022.100171_bib32) 1986; 324 Kos (10.1016/j.jtauto.2022.100171_bib8) 2021; 51 Carfì (10.1016/j.jtauto.2022.100171_bib2) 2020; 324 |
| References_xml | – volume: 22 start-page: e102 year: 2022 end-page: e107 ident: bib4 article-title: A clinical case definition of post-COVID-19 condition by a Delphi consensus publication-title: Lancet Infect. Dis. – volume: 132 start-page: 2744 year: 2018 end-page: 2753 ident: bib26 article-title: Hyper- N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma publication-title: Blood – volume: 12 start-page: 3876 year: 2020 ident: bib9 article-title: Prothrombotic autoAbs in serum from patients hospitalized with COVID-19 publication-title: Sci. Transl. Med. – volume: 4 year: 2020 ident: bib16 article-title: Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders publication-title: Brain, Behavior, & Immunity - Health – volume: 20 year: 2021 ident: bib10 article-title: AutoAbs in COVID-19: frequency and function publication-title: Autoimmun. Rev. – volume: 12 start-page: 1 year: 2021 end-page: 15 ident: bib11 article-title: New-onset IgG autoAbs in hospitalized patients with COVID-19 publication-title: Nat. Commun. – volume: 12 year: 2022 ident: bib5 article-title: Protocol: LOng COvid Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK publication-title: BMJ Open – volume: 36 start-page: 87 year: 2011 end-page: 90 ident: bib22 article-title: Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin publication-title: J. Autoimmun. – volume: 10 year: 2020 ident: bib28 article-title: Integration of the B-cell receptor antigen neurabin-I/SAMD14 into an antibody format as new therapeutic approach for the treatment of primary CNS lymphoma publication-title: Front. Oncol. – volume: 101 start-page: 273 year: 1998 end-page: 281 ident: bib33 article-title: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoAbs publication-title: J. Clin. Investig. – volume: 7 start-page: 271 year: 2019 end-page: 275 ident: bib29 article-title: Progranulin autoAbs in systemic sclerosis and autoimmune connective tissue disorders: a preliminary study publication-title: Immun Inflamm Dis – volume: 42 start-page: 29 year: 2013 end-page: 38 ident: bib25 article-title: Progranulin antibodies in autoimmune diseases publication-title: J. Autoimmun. – volume: 125 start-page: 656 year: 2009 end-page: 661 ident: bib21 article-title: A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS publication-title: Int. J. Cancer – reference: Thurner L, Fadle N, Bewarder M, et al. AutoAbs against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19. bioRxiv. Published online October 20, 2021:2021.04.23.441188. doi:10.1101/2021.04.23.441188. – volume: 28 year: 2022 ident: bib6 article-title: Female gender is associated with long COVID syndrome: a prospective cohort study publication-title: Clin. Microbiol. Infect. – volume: 149 start-page: 63 year: 2022 ident: bib15 article-title: COVID-19 as an infectome paradigm of autoimmunity publication-title: J. Allergy Clin. Immunol. – volume: 13 start-page: 1077 year: 2020 end-page: 1086 ident: bib14 article-title: Clinical and autoimmune characteristics of severe and critical cases of COVID-19 publication-title: Clin Transl Sci – volume: 324 start-page: 603 year: 2020 end-page: 605 ident: bib2 article-title: Persistent symptoms in patients after acute COVID-19 publication-title: JAMA – volume: 12 start-page: 4065 year: 2021 ident: bib31 article-title: PADI4 polymorphisms confer risk of anti-CCP-positive rheumatoid arthritis in synergy with HLA-drb1*04 and smoking publication-title: Front. Immunol. – volume: 73 start-page: E4058 year: 2021 end-page: E4063 ident: bib3 article-title: Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients publication-title: Clin. Infect. Dis. – volume: 20 year: 2021 ident: bib7 article-title: The SARS-CoV-2 as an instrumental trigger of autoimmunity publication-title: Autoimmun. Rev. – volume: 106 start-page: 2543 year: 2009 end-page: 2548 ident: bib24 article-title: Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 4 start-page: e329 year: 2022 end-page: e337 ident: bib20 article-title: AutoAbs against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study publication-title: The Lancet Rheumatology – start-page: 370 year: 2020 ident: bib13 article-title: AutoAbs against type I IFNs in patients with life-threatening COVID-19 publication-title: Science – volume: 65 start-page: 639 year: 2009 end-page: 649 ident: bib30 article-title: Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid publication-title: Ann. Neurol. – volume: 72 start-page: 1953 year: 2020 end-page: 1955 ident: bib12 article-title: Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity publication-title: Arthritis Rheumatol. – volume: 4 year: 2021 ident: bib18 article-title: Functional autoAbs against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms publication-title: Journal of Translational Autoimmunity – volume: 5 start-page: E620 year: 2021 ident: bib27 article-title: The B-cell receptor autoantigen LRPAP1 can replace variable antibody regions to target mantle cell lymphoma cells publication-title: Hemasphere – volume: 125 start-page: 316 year: 2015 end-page: 323 ident: bib23 article-title: Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor publication-title: J. Clin. Invest. – volume: 76 start-page: 399 year: 2021 end-page: 401 ident: bib1 article-title: Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort publication-title: Thorax – volume: 324 start-page: 258 year: 1986 end-page: 260 ident: bib32 article-title: T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis publication-title: Nature – volume: 9 year: 2018 ident: bib17 article-title: Bidirectional role of β2-adrenergic receptor in autoimmune diseases publication-title: Front. Pharmacol. – volume: 51 start-page: 1449 year: 2021 end-page: 1460 ident: bib8 article-title: Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients publication-title: Eur. J. Immunol. – volume: 28 issue: 4 year: 2022 ident: 10.1016/j.jtauto.2022.100171_bib6 article-title: Female gender is associated with long COVID syndrome: a prospective cohort study publication-title: Clin. Microbiol. Infect. doi: 10.1016/j.cmi.2021.11.002 – volume: 10 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib28 article-title: Integration of the B-cell receptor antigen neurabin-I/SAMD14 into an antibody format as new therapeutic approach for the treatment of primary CNS lymphoma publication-title: Front. Oncol. doi: 10.3389/fonc.2020.580364 – volume: 7 start-page: 271 issue: 4 year: 2019 ident: 10.1016/j.jtauto.2022.100171_bib29 article-title: Progranulin autoAbs in systemic sclerosis and autoimmune connective tissue disorders: a preliminary study publication-title: Immun Inflamm Dis doi: 10.1002/iid3.270 – volume: 51 start-page: 1449 issue: 6 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib8 article-title: Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients publication-title: Eur. J. Immunol. doi: 10.1002/eji.202049163 – volume: 132 start-page: 2744 issue: 26 year: 2018 ident: 10.1016/j.jtauto.2022.100171_bib26 article-title: Hyper- N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma publication-title: Blood doi: 10.1182/blood-2018-03-836932 – volume: 12 start-page: 1 issue: 1 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib11 article-title: New-onset IgG autoAbs in hospitalized patients with COVID-19 publication-title: Nat. Commun. doi: 10.1038/s41467-021-25509-3 – volume: 12 start-page: 3876 issue: 570 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib9 article-title: Prothrombotic autoAbs in serum from patients hospitalized with COVID-19 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abd3876 – volume: 101 start-page: 273 issue: 1 year: 1998 ident: 10.1016/j.jtauto.2022.100171_bib33 article-title: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoAbs publication-title: J. Clin. Investig. doi: 10.1172/JCI1316 – volume: 125 start-page: 316 issue: 1558–8238 year: 2015 ident: 10.1016/j.jtauto.2022.100171_bib23 article-title: Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor publication-title: J. Clin. Invest. doi: 10.1172/JCI76802 – volume: 12 start-page: 4065 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib31 article-title: PADI4 polymorphisms confer risk of anti-CCP-positive rheumatoid arthritis in synergy with HLA-drb1*04 and smoking publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.707690 – volume: 149 start-page: 63 issue: 1 year: 2022 ident: 10.1016/j.jtauto.2022.100171_bib15 article-title: COVID-19 as an infectome paradigm of autoimmunity publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2021.11.009 – ident: 10.1016/j.jtauto.2022.100171_bib19 doi: 10.1101/2021.04.23.441188 – volume: 4 start-page: e329 issue: 5 year: 2022 ident: 10.1016/j.jtauto.2022.100171_bib20 article-title: AutoAbs against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study publication-title: The Lancet Rheumatology doi: 10.1016/S2665-9913(22)00064-9 – volume: 20 issue: 4 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib7 article-title: The SARS-CoV-2 as an instrumental trigger of autoimmunity publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2021.102792 – volume: 72 start-page: 1953 issue: 11 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib12 article-title: Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity publication-title: Arthritis Rheumatol. doi: 10.1002/art.41409 – volume: 13 start-page: 1077 issue: 6 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib14 article-title: Clinical and autoimmune characteristics of severe and critical cases of COVID-19 publication-title: Clin Transl Sci doi: 10.1111/cts.12805 – volume: 22 start-page: e102 issue: 4 year: 2022 ident: 10.1016/j.jtauto.2022.100171_bib4 article-title: A clinical case definition of post-COVID-19 condition by a Delphi consensus publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(21)00703-9 – volume: 9 issue: NOV year: 2018 ident: 10.1016/j.jtauto.2022.100171_bib17 article-title: Bidirectional role of β2-adrenergic receptor in autoimmune diseases publication-title: Front. Pharmacol. – volume: 106 start-page: 2543 issue: 8 year: 2009 ident: 10.1016/j.jtauto.2022.100171_bib24 article-title: Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.0812892106 – volume: 76 start-page: 399 issue: 4 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib1 article-title: Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort publication-title: Thorax doi: 10.1136/thoraxjnl-2020-216086 – volume: 324 start-page: 603 issue: 6 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib2 article-title: Persistent symptoms in patients after acute COVID-19 publication-title: JAMA doi: 10.1001/jama.2020.12603 – volume: 125 start-page: 656 issue: 1097–0215 year: 2009 ident: 10.1016/j.jtauto.2022.100171_bib21 article-title: A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS publication-title: Int. J. Cancer doi: 10.1002/ijc.24427 – volume: 5 start-page: E620 issue: 8 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib27 article-title: The B-cell receptor autoantigen LRPAP1 can replace variable antibody regions to target mantle cell lymphoma cells publication-title: Hemasphere doi: 10.1097/HS9.0000000000000620 – volume: 12 issue: 5 year: 2022 ident: 10.1016/j.jtauto.2022.100171_bib5 article-title: Protocol: LOng COvid Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): protocol for a mixed-methods study in the UK publication-title: BMJ Open doi: 10.1136/bmjopen-2022-063505 – volume: 324 start-page: 258 issue: 6094 year: 1986 ident: 10.1016/j.jtauto.2022.100171_bib32 article-title: T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis publication-title: Nature doi: 10.1038/324258a0 – volume: 73 start-page: E4058 issue: 11 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib3 article-title: Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa1792 – volume: 36 start-page: 87 issue: 1 year: 2011 ident: 10.1016/j.jtauto.2022.100171_bib22 article-title: Wegener's granuloma harbors B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2010.09.002 – volume: 4 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib16 article-title: Dysregulation of G protein-coupled receptors of the autonomic nervous system, adrenergic and muscarinic acetylcholine receptors, in patients with autoimmune dysautonomic-related disorders publication-title: Brain, Behavior, & Immunity - Health doi: 10.1016/j.bbih.2020.100056 – start-page: 370 issue: 6515 year: 2020 ident: 10.1016/j.jtauto.2022.100171_bib13 article-title: AutoAbs against type I IFNs in patients with life-threatening COVID-19 publication-title: Science – volume: 42 start-page: 29 year: 2013 ident: 10.1016/j.jtauto.2022.100171_bib25 article-title: Progranulin antibodies in autoimmune diseases publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2012.10.003 – volume: 4 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib18 article-title: Functional autoAbs against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms publication-title: Journal of Translational Autoimmunity doi: 10.1016/j.jtauto.2021.100100 – volume: 65 start-page: 639 issue: 6 year: 2009 ident: 10.1016/j.jtauto.2022.100171_bib30 article-title: Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid publication-title: Ann. Neurol. doi: 10.1002/ana.21641 – volume: 20 issue: 3 year: 2021 ident: 10.1016/j.jtauto.2022.100171_bib10 article-title: AutoAbs in COVID-19: frequency and function publication-title: Autoimmun. Rev. |
| SSID | ssj0002511162 |
| Score | 2.214385 |
| Snippet | Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting... |
| SourceID | doaj pubmedcentral proquest crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 100171 |
| Title | Autoantibodies against SUMO1-DHX35 in long-COVID |
| URI | https://dx.doi.org/10.1016/j.jtauto.2022.100171 https://www.proquest.com/docview/2740513136 https://pubmed.ncbi.nlm.nih.gov/PMC9675633 https://doaj.org/article/345009a341144122b1a26a056a890e1e |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlEOil5FW6abK40Kuo9bKk4-axbAtpLknZm5C8cuoQvCHxHvrvM2PZYX3aS6_2SJZn5JlP8ugbQr5XK2NXQUQKaDWnEkIqtSYqGnXUIoZSaY6nkW9-F4t7-WupllulvjAnLNEDJ8X9EFIBDPDgbBH6cx6Y54WHsO2NzSOL6H1zm28tptAHI3BmXTVRroylFiSGc3Ndctdj6zctnv3jvGMh0mwUlzr6_lF42oKf4-TJrWg0PyCfehiZzdLwD8mH2ByR_VRY8t8xyWfwXNBZHdaYJZj5B18DDszAh94yerVYCpXVTfa0bh7o5e2fn1cn5H5-fXe5oH1tBFqqvGipyoUKtuKmqoRWynimYOWDfIuqNPkKeeE0jz5wHXTBKlsqyVASwrkQqgziM9lr1k38QjIPBglBGxZZKYXERkUZDOBCKbk0fELEoBlX9sThWL_iyQ0ZYo8u6dOhPl3S54TQ91bPiThjh_wFKv1dFmmvuwswGVw_GdyuyTAhejCZ6xFEQgbQVb3j8d8GCzv4wPCviW_ievPqYNkOjkswUUDvI9OPxjq-09R_O6puC-uxQojT__FyX8lHHHDa_zkje-3LJp4DImrDtJv8026r6g0V4gKb |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autoantibodies+against+SUMO1-DHX35+in+long-COVID&rft.jtitle=Journal+of+translational+autoimmunity+%28Online%29&rft.au=Thurner%2C+Lorenz&rft.au=Fadle%2C+Natalie&rft.au=Regitz%2C+Evi&rft.au=Preuss%2C+Klaus-Dieter&rft.date=2022-01-01&rft.issn=2589-9090&rft.eissn=2589-9090&rft.volume=5&rft.spage=100171&rft_id=info:doi/10.1016%2Fj.jtauto.2022.100171&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2589-9090&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2589-9090&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2589-9090&client=summon |